News for 'Sun Pharmaceuticals'

Bilateral trade: No direct impact of Russia-Ukraine crisis on India

Bilateral trade: No direct impact of Russia-Ukraine crisis on India

Rediff.com25 Feb 2022

There is no direct impact of the Russia-Ukraine crisis on India in terms of bilateral trade but a surge in oil prices poses considerable risk to the economy, an analyst report said on Friday. International oil prices which have surged past $100 per barrel "pose risks to external stability and currency movement," a Bank of Baroda Economics Research report said. Russia has launched military operations against Ukraine, stoking fears of significant disruption in the region, including loss of life. The West is ramping up financial sanctions against Russia and support for Ukraine.

IPO frenzy continues; 2 public issues to open on Sep 1

IPO frenzy continues; 2 public issues to open on Sep 1

Rediff.com29 Aug 2021

The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.

ASK AJIT: Stocks To Buy, Hold, Sell

ASK AJIT: Stocks To Buy, Hold, Sell

Rediff.com11 Mar 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Rediff.com3 Aug 2021

On April 14, 2016, the crime branch of the Thane police had seized over 20 tonnes of ephedrine and 2.5 tonnes of acetic anhydride drugs from a pharmaceutical factory - Avon Life Sciences - in Solapur and other locations in Thane and Ahmedabad.

The bizarre tale of Cairn retro tax

The bizarre tale of Cairn retro tax

Rediff.com6 Mar 2022

The levy of retrospective tax on the UK's Cairn Energy Plc is a tale of bizarre twists and turns that saw its attached shares being sold in May 2018 amid the passing of the baton from a full-time finance minister to interim one and the talks at the highest level to resolve the dispute, to claims that levy of back taxes was a result of an investigation into Panama Papers leak. The government late last month refunded about Rs 7,900 crore it had collected from selling residual shares of the British firm in its erstwhile India unit, seizing dividend and withholding tax refunds, to settle an eight-year-old dispute that had tarred the country's reputation as an investment destination. But, this did not come about easily. For seven years, the establishment vehemently justified in courts and outside seeking of Rs 10,247 crore in back taxes plus interest and penalty from a firm that gave India its biggest onshore oil discovery.

PM chairs all-party meeting on COVID-19 situation

PM chairs all-party meeting on COVID-19 situation

Rediff.com4 Dec 2020

This will be the second all-party meeting called by the government to discuss the COVID-19 situation since the outbreak of the pandemic.

India Inc cutting employee costs as coronavirus hurts recovery

India Inc cutting employee costs as coronavirus hurts recovery

Rediff.com19 Aug 2020

June indicates a change in trend from previous quarters in terms of how much companies are spending on employees. The worst hit sectors included steel, air transport service and automobile firms.

Exports jump 58.23% to $34 bn in March

Exports jump 58.23% to $34 bn in March

Rediff.com1 Apr 2021

The country's exports jumped by 58.23 per cent to $34 billion in March as key sectors such as engineering, gems and jewellery and pharmaceuticals recorded healthy growth rate during the month, according to the Commerce Ministry's provisional data. Exports during April-March 2020-21, however, dipped by 7.4 per cent to $290.18 billion compared to $313.36 billion in 2019-20, the data showed. Imports during 2020-21 contracted by 18 per cent to $388.92 billion compared to $474.71 billion during 2019-20. In March 2020, the exports stood at $21.49 billion, which was a decline of about 34 per cent over March 2019 due to global slowdown induced by the Covid-19 crisis.

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

Serum to supply 22cr Covishield doses to Centre in October

Serum to supply 22cr Covishield doses to Centre in October

Rediff.com21 Sep 2021

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said.

Masks, hand sanitiser declared 'essential commodities'

Masks, hand sanitiser declared 'essential commodities'

Rediff.com14 Mar 2020

These items will remain under essential commodities segment till June-end, a move aimed at ensuring availability at reasonable prices and cracking down on hoarders/black marketeers.

'We have to do everything to avoid a super spreader event'

'We have to do everything to avoid a super spreader event'

Rediff.com1 Jan 2022

'Health will continue to be at the centre of the government's attention as it underpins economic recovery and our collective well being.'

India has 100 unicorns valued at $240bn, bulk of them in Bengaluru

India has 100 unicorns valued at $240bn, bulk of them in Bengaluru

Rediff.com23 Mar 2021

These unicorns, or startups valued at over USD 1 billion, are across industries, beyond technology and tech-enabled sectors as well, like pharmaceuticals, and consumer goods, Credit Suisse India equity strategist Neelkanth Mishra told reporters in Mumbai.

Govt developing multi-variant Covid-19 vaccine

Govt developing multi-variant Covid-19 vaccine

Rediff.com14 Sep 2021

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.

Pfizer, Moderna won't sell Covid vaccines to Delhi: CM

Pfizer, Moderna won't sell Covid vaccines to Delhi: CM

Rediff.com24 May 2021

Pfizer and Moderna said they won't give us vaccine and will directly talk to the Centre," Kejriwal told reporters.

'Every company wants to recruit people'

'Every company wants to recruit people'

Rediff.com10 Nov 2021

'There was hardly any recruitment after the second wave.' 'Now, there is a huge demand for manpower.'

Retro Tax: Cairn drops lawsuits in US, UK

Retro Tax: Cairn drops lawsuits in US, UK

Rediff.com26 Dec 2021

Britain's Cairn Energy Plc has dropped lawsuits against the Indian government and its entities in the US and other places and is in the final stages of withdrawing cases in Paris and the Netherlands to get back about Rs 7,900 crore that were collected from it to enforce a retrospective tax demand. As part of the settlement reached with the government to the seven-year old dispute over levy of back taxes, the company - which is now known as Capricorn Energy PLC - has initiated proceedings to withdraw lawsuits it had filed in several jurisdictions to enforce an international arbitration award which had overturned levy of Rs 10,247 crore retrospective taxes and ordered India to refund the money already collected. Two sources with direct knowledge of the matter said Cairn on November 26 withdrew the lawsuit it had brought in Mauritius for recognition of the arbitration award and took similar measures in courts in Singapore, the UK and Canada.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

September 1st week exports jump 13.35%, imports down 21.37%

September 1st week exports jump 13.35%, imports down 21.37%

Rediff.com10 Sep 2020

India's exports during the first week of September jumped 13.35 per cent year-on-year to $ 6.12 billion, official data released on Thursday showed. At the same time, imports declined by 21.37 per cent to $ 6.85 billion. Consequently, the deficit during September 1 to 7 worked out to $ 730 million.

'Sputnik V provides immunity for a longer duration'

'Sputnik V provides immunity for a longer duration'

Rediff.com26 Jul 2021

'Its efficacy is 97.6 per cent.'

SII to raise monthly production to 10 cr doses by Aug, Bharat Biotech promises 7.8 cr

SII to raise monthly production to 10 cr doses by Aug, Bharat Biotech promises 7.8 cr

Rediff.com12 May 2021

Several states and UTs including Delhi, Maharashtra, Karnataka and Telangana have decided to opt for global tenders for procurement of anti-coronavirus shots with the domestic supply falling short to meet the rising demand.

HDFC Bank ex-CEO Aditya Puri joins Carlyle as senior advisor

HDFC Bank ex-CEO Aditya Puri joins Carlyle as senior advisor

Rediff.com2 Nov 2020

Former HDFC Bank CEO Aditya Puri will be guiding global Carlyle on investment opportunities across Asia as a senior advisor, the global private equity major said on Monday.

Stocks You Must AVOID or EXIT

Stocks You Must AVOID or EXIT

Rediff.com26 Apr 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

ASK AJIT: How to get 20% return on shares?

ASK AJIT: How to get 20% return on shares?

Rediff.com17 Dec 2021

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

Why 1,700 employees of Pfizer's India arm may lose their jobs

Why 1,700 employees of Pfizer's India arm may lose their jobs

Rediff.com10 Jan 2019

A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.

Trump has not been tested for coronavirus: White House

Trump has not been tested for coronavirus: White House

Rediff.com10 Mar 2020

Trump was in contact with multiple lawmakers who have since gone into self-imposed quarantine.

ITC diversifying tobacco biz to capture US vaping market

ITC diversifying tobacco biz to capture US vaping market

Rediff.com16 Jul 2021

The facility, which will manufacture nicotine and nicotine salts, will conform to stringent US and EU pharmacopoeia standards that define purity levels at 99.2 per cent for nicotine meant for pharmaceutical products. ITC will leverage the institutional capabilities of its century-old leaf tobacco business for this. ITC's cigarettes business saw disruptions across the value chain with the onset of the Covid-19 pandemic. The company mentioned in its annual report that with easing of restrictions and improvement in mobility from September 2020 onwards, the business recovered progressively over the remainder of the year to reach nearly pre-Covid levels towards the close of the year.

Union minister Gowda courts quarantine controversy

Union minister Gowda courts quarantine controversy

Rediff.com25 May 2020

Sadananda Gowda, the minister, also Bengaluru North MP, drove off in an official car with out undergoing institutional quarantine as mandated by the Karnataka government for air travellers coming from high COVID-19 prevalence states after arriving by a commercial airline flight, services of which resumed after two months.

Invest in Aurobindo Pharma only for a long term

Invest in Aurobindo Pharma only for a long term

Rediff.com22 Feb 2021

The focus of the company would be to develop its capability across segments of injectables, vaccines, biosimilars, inhalation and APIs to drive growth.

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

The TOP job trends in India

The TOP job trends in India

Rediff.com16 Jun 2021

Hiring for management professionals with greater than 16 years of experience witnessed a spike of 66% compared to last year.

Hiring activity jumps 15% in June

Hiring activity jumps 15% in June

Rediff.com8 Jul 2021

Hiring activity in the country, which was hit by the second COVID wave, bounced back with a 15 per cent growth in June compared to May, according to a report. The activity was led by the IT-software/software services sector. The latest Naukri JobSpeak report on Thursday said that India's hiring trends grew 15 per cent in June with 2,359 job postings from 2,047 in May.

Pandemic has IFC pumping $1.7 bn in India

Pandemic has IFC pumping $1.7 bn in India

Rediff.com17 Aug 2021

The pandemic has led to the International Finance Corporation massively ramping up its impact investment in the country - its largest client nation globally - at $1.7 billion as of June, a 51 per cent rise over the past 12 months, the largest developmental lender into third world private sector said on Tuesday. This is nearly half of its investment in the whole of South Asia since the pandemic, which touched $3.8 billion as of June 2021, it said. "Our total commitment to India, which is our largest client country globally, at the end of June stood at $1.7 billion representing an increase of over 51 per cent from last year," IFC vice-president for Asia and the Pacific region Alfonso Garcia Mora said in a statement.

Continuous efforts being made to ramp up vaccine supply: Modi

Continuous efforts being made to ramp up vaccine supply: Modi

Rediff.com18 May 2021

Describing state and district officials as 'field commanders' in the fight against COVID-19, Prime Minister Narendra Modi on Tuesday said localised containment zones, aggressive testing and sharing correct and complete information with people are weapons to defeat the pandemic.

Why US' revocation may not have much effect on HCQs exports

Why US' revocation may not have much effect on HCQs exports

Rediff.com17 Jun 2020

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis and autoimmune lupus.

Cairn, Air India seek stay on New York court proceedings

Cairn, Air India seek stay on New York court proceedings

Rediff.com15 Sep 2021

Cairn Energy and Air India have jointly asked a New York federal court to stay further proceedings in the British firm's US lawsuit targeting the airline for enforcement of a $1.2-billion arbitral award. The move follows the government enacting a law to scrap retrospective taxation in the country, which in effect will result in withdrawal of the Rs 10,247 crore tax demand on Cairn, according to court documents reviewed by PTI. The British company had won an international arbitration award against levy of such taxes and sought to take over Air India assets when the government refused to honour the award and pay it $1.2 billion-plus interest and penalty.

Hindujas sell health care unit to Baring Private Equity for $1.2 billion

Hindujas sell health care unit to Baring Private Equity for $1.2 billion

Rediff.com11 Aug 2021

Hinduja Group's business process management entity, Hinduja Global Solutions Limited (HGS) said on Wednesday that it has entered into definitive agreements to divest its Healthcare Services business to funds affiliated with Baring Private Equity Asia (BPEA), at an enterprise value of $1.2 bilion. The deal is subject to closing adjustments, and is expected to complete within 90 days, subject to shareholder and other regulatory approvals. "The cash that will come in as a result of this transaction will be deployed to growing the business as well as looking at buying some capabilities...where capabilities are important for being able to do a good job of customer experience transformation.

Sputnik V vaccine to be available in India from next week: Govt

Sputnik V vaccine to be available in India from next week: Govt

Rediff.com14 May 2021

India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi.

Finmin reimposes spending curbs on ministries, depts for Q2

Finmin reimposes spending curbs on ministries, depts for Q2

Rediff.com1 Jul 2021

The finance ministry on Wednesday reimposed expenditure curbs on ministries and government departments for July-September quarter. There will be no spending restrictions on the ministries of health, rural development, agriculture, MSME (micro, small and medium enterprises) and railways as part of a two-pronged strategy. "The existing guidelines for expenditure control have been reviewed. "Keeping in view the evolving situation arising out of Covid-19 and anticipated cash position of the government, it is felt essential to regulate Quarterly Expenditure Plan (QEP)/Monthly Expenditure Plan (MEP) of specific ministries/departments for July-September, 2021," the Department of Economic Affairs in the finance ministry said in a notification.